Verfügbare Impfstoffproduktionskapazitäten im Rahmen von Pandemiebereitschaftsverträgen

This question asks about the availability of vaccine production capacity under pandemic preparedness contracts. It seeks to understand the EU's readiness to respond to future health crises through secured manufacturing capabilities. The focus is on ensuring that sufficient vaccine production can be ramped up quickly during a pandemic, potentially affecting public health services and pharmaceutical companies.